These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20619105)
41. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells]. Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482 [TBL] [Abstract][Full Text] [Related]
42. Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro. Xu M; Wang Y; Chen L; Pan B; Chen F; Fang Y; Yu Z; Chen G Gene; 2014 Feb; 536(1):84-9. PubMed ID: 24334120 [TBL] [Abstract][Full Text] [Related]
43. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711 [TBL] [Abstract][Full Text] [Related]
44. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53. Niu J; Xu Z; Li XN; Han Z Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318 [TBL] [Abstract][Full Text] [Related]
45. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells. Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570 [TBL] [Abstract][Full Text] [Related]
46. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664 [TBL] [Abstract][Full Text] [Related]
47. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484 [TBL] [Abstract][Full Text] [Related]
48. PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. Sato F; Nagata C; Liu Y; Suzuki T; Kondo J; Morohashi S; Imaizumi T; Kato Y; Kijima H J Biochem; 2009 Dec; 146(6):833-8. PubMed ID: 19675098 [TBL] [Abstract][Full Text] [Related]
49. Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer. Zhang YL; Zhang YC; Han W; Li YM; Wang GN; Yuan S; Wei FX; Wang JF; Jiang JJ; Zhang YW World J Gastroenterol; 2014 Aug; 20(32):11287-96. PubMed ID: 25170213 [TBL] [Abstract][Full Text] [Related]
50. Very low density lipoprotein receptor subtype II silencing by RNA interference inhibits cell proliferation in hepatoma cell lines. Luo M; Liu YJ; Xia LM; Yan W; Zhu Q; Tian DA Hepatogastroenterology; 2010; 57(101):882-90. PubMed ID: 21033246 [TBL] [Abstract][Full Text] [Related]
51. RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Zamora-Avila DE; Franco-Molina MA; Trejo-Avila LM; Rodríguez-Padilla C; Reséndez-Pérez D; Zapata-Benavides P Melanoma Res; 2007 Dec; 17(6):341-8. PubMed ID: 17992115 [TBL] [Abstract][Full Text] [Related]
52. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells. Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983 [TBL] [Abstract][Full Text] [Related]
53. Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro. Ibrahim MM; Sun MZ; Huang Y; Jun M; Jin Y; Yue D; Jiasheng W; Zhang J; Qazi AS; Sagoe K; Tang J Biomed Pharmacother; 2013 May; 67(4):285-91. PubMed ID: 23582794 [TBL] [Abstract][Full Text] [Related]
54. Silencing of the Zhang J; Ma H; Yang L; Yang H; He Z J Int Med Res; 2019 Mar; 47(3):1319-1329. PubMed ID: 30678511 [TBL] [Abstract][Full Text] [Related]
55. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2]. Xu KS; Wang HF; Qian W; Wang BH Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364 [TBL] [Abstract][Full Text] [Related]
56. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis. Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046 [TBL] [Abstract][Full Text] [Related]
57. [Construction of shRNA eucharyotic expression plasmid targeted human VIGILIN and the investigation of VIGILIN's effect on hepatocarcinoma cell cycle]. Xie XY; Wei L; Yang WL; Ge YJ; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):527-30, 539. PubMed ID: 18798485 [TBL] [Abstract][Full Text] [Related]
58. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302 [TBL] [Abstract][Full Text] [Related]
59. [Inhibitory effect of lentivirus transduced anti-telomerase siRNA therapy on hepatocellular carcinoma in nude mice]. Zhang Y; Gao Y; Xi LS; Deng L; Yin AH; Wang XH; Sun BC Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):410-3. PubMed ID: 19950547 [TBL] [Abstract][Full Text] [Related]
60. [Expression of annexin I in human pancreatic cancer and the influence of its down-regulation on biology of this cancer]. Liu Q; Wang CF; Zhou Z; Hu H; Zhao DB; Ni XG; Bai XF; Gao JD; Tian YT; Zhao P Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):738-41. PubMed ID: 18396684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]